Barely Significant
← all excerpts

Impact of encorafenib on survival of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in a real-world setting.

J Cancer Res Clin Oncol · 2023 · PMC10587317 · PMID 37466791

Europe PMCDOI
1
hedged sentence
0.0860
closest p · 1.7× alpha
0.0860
boldest claim

The sentences

did not reach statistical significancep = 0.086so close (0.05 < p ≤ 0.1)
This difference did not reach statistical significance ( p = 0.086) given the low number of patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.